United States· US:23155-055_61e37b1d-f036-4c35-9073-ce456efd8007

naratriptan

A naratriptan product containing naratriptan hydrochloride, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 15 of our 19 countries.

ATC N02CC02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisednaratriptanATCN02CC02REGISTER NO.US:23155-055_61e37b1d…PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Naratriptan is registered in 15 of 19 countries.

Countries holding a registration under ATC N02CC02 (naratriptan), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Naratriptan · ATC N02CC02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of naratriptan costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.25 in France to $6.45 in Switzerland — a ×5.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Naratriptan · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$6.45
  • ES Spain$3.63
  • FR France$1.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NARATRIPTAN HYDROCHLORIDE
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country
United States (US)
ATC code
N02CC02
ATC class
Naratriptan
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    2315505503
    30 TABLET in 1 BOTTLE (23155-055-03)
  • ndc11
    2315505505
    500 TABLET in 1 BOTTLE (23155-055-05)
  • ndc11
    2315505519
    9 TABLET in 1 BLISTER PACK (23155-055-19)
  • ndc11
    23155-055-03
  • ndc11
    23155-055-05
  • ndc11
    23155-055-19

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

50 interactions on record for naratriptan.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Naratriptan · interactions on record

50 records

  • 11 severe
  • 6 moderate
  • 5 minor
  • 27 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naratriptan in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naratriptan products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Belgium · Naramig, Naratriptan Sandoz
  • Bulgaria · Нарворан Мигрена
  • Czechia · Naramig
  • Germany · Formigran, Naradex
  • Denmark · Naratriptan Teva, Naxtrin
  • Spain · Naramig
  • Finland · Naramig, Naratriptan Orifarm
  • France · Naramig, Naratriptan Arrow
  • United Kingdom (Northern Ireland) · Naramig, Naratriptan
  • Ireland · Naratriptan 2.5 Mg Tablet, Naraverg
  • Lithuania · Naramig, Naratriptan Inteli
  • Luxembourg · Naramig
  • Malta · Naratriptan Renata Pharmaceuticals (Ireland)
  • Netherlands · Naramig, Naratriptan Cf
  • Norway · Naratriptan Orifarm, Naxtrin
  • Portugal · Naramig, Naratriptano Renata
  • Romania · Nacralid, Naratriptan Stada Hemofarm
  • Sweden · Naramig, Naratriptan Orifarm
  • Slovenia · Naramig

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecfdbbeb-9e07-4ede-9fcc-5a8b053516be
GET /v1/drugs/ecfdbbeb-9e07-4ede-9fcc-5a8b053516be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.5",
  "substance": "NARATRIPTAN HYDROCHLORIDE",
  "productndc": "23155-055",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA200502",
  "marketing_category": "ANDA"
}

See everything about naratriptan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.